Literature DB >> 7871019

Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.

A Woods1, C Smith, M Szewczak, R W Dunn, M Cornfeldt, R Corbett.   

Abstract

Schedule-induced polydipsia was used to determine the effects of selective serotonin re-uptake inhibitors on adjunctive water consumption. Polydipsia was induced in food deprived rats by exposure to a fixed time feeding schedule (FT = 60 s) for 150 min per day for 22 days. Selected polydipsic rats consumed 3-4 times greater volume of water compared to food deprived control rats. Chronic administration of the selective serotonin re-uptake inhibitors fluoxetine and clomipramine (CMI) at 5 mg/kg per day and fluvoxamine at 10 mg/kg twice a day significantly decreased schedule-induced polydipsia (SIP) on day 15 and throughout the remainder of the study compared to control rats. The noradrenergic re-uptake inhibitor, desipramine (DMI), only decreased SIP behavior on day 1. The neuroleptic, haloperidol (0.03 and 0.1 mg/kg), and the benzodiazepine, diazepam (2.5 mg/kg), failed to alter SIP behavior. Since obsessive-compulsive disorder (OCD) and polydipsic behavior both involve excessive expression of a normal behavior, the polydipsia model may be relevant for the prediction of compounds useful in the treatment of OCD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871019     DOI: 10.1007/bf02244910

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

Review 1.  Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Authors:  W K Goodman; C J McDougle; L H Price; M A Riddle; D L Pauls; J F Leckman
Journal:  J Clin Psychiatry       Date:  1990-08       Impact factor: 4.384

2.  Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Authors:  W K Goodman; L H Price; P L Delgado; J Palumbo; J H Krystal; L M Nagy; S A Rasmussen; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1990-06

Review 3.  Obsessive-compulsive disorder: a neuroethological perspective.

Authors:  T R Insel
Journal:  Psychopharmacol Bull       Date:  1988

4.  Schedule-induced drinking and thirst: a pharmacological analysis.

Authors:  D J Sanger; P K Corfield-Sumner
Journal:  Pharmacol Biochem Behav       Date:  1979-04       Impact factor: 3.533

5.  Treatment of obsessive--compulsive neurosis with haloperidol.

Authors:  J B O'Regan
Journal:  Can Med Assoc J       Date:  1970-07-18       Impact factor: 8.262

6.  Treatment of obsessive-compulsive neurosis.

Authors:  M Z Hussain; A Ahad
Journal:  Can Med Assoc J       Date:  1970-09-26       Impact factor: 8.262

Review 7.  The nature and determinants of adjunctive behavior.

Authors:  J L Falk
Journal:  Physiol Behav       Date:  1971-05

8.  Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine.

Authors:  P Willner; J McGuirk; G Phillips; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.

Authors:  P Blier; Y Chaput; C de Montigny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

10.  Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder?

Authors:  E Yadin; E Friedman; W H Bridger
Journal:  Pharmacol Biochem Behav       Date:  1991-10       Impact factor: 3.533

View more
  30 in total

Review 1.  Applications of schedule-induced polydipsia in rodents for the study of an excessive ethanol intake phenotype.

Authors:  Matthew M Ford
Journal:  Alcohol       Date:  2014-02-28       Impact factor: 2.405

2.  Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia.

Authors:  Silvia Victoria Navarro; Valeria Gutiérrez-Ferre; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2014-08-26       Impact factor: 4.530

Review 3.  Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

Authors:  John Dunlop; Karen L Marquis; H K Lim; Louis Leung; John Kao; Cynthia Cheesman; Sharon Rosenzweig-Lipson
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

4.  Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.

Authors:  C E Beyer; Q Lin; B Platt; J Malberg; G Hornby; K M Sullivan; D L Smith; T Lock; P J Mitchell; N T Hatzenbuhler; D A Evrard; B L Harrison; R Magolda; M N Pangalos; L E Schechter; S Rosenzweig-Lipson; T H Andree
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

5.  Serotonergic activity of HP 184: does spontaneous release have a role?

Authors:  C P Smith; A T Woods-Kettelberger; R Corbett; S M Chesson; G M Bores; W W Petko; J E Roehr; S Kongsamut
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

Review 6.  Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Authors:  Susan M Cheer; David P Figgitt
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Vulnerability of long-term neurotoxicity of chlorpyrifos: effect on schedule-induced polydipsia and a delay discounting task.

Authors:  D Cardona; M López-Grancha; G López-Crespo; F Nieto-Escamez; F Sánchez-Santed; P Flores
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

Review 8.  Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment.

Authors:  N A Fineberg; S R Chamberlain; E Hollander; V Boulougouris; T W Robbins
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

9.  Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

Authors:  Gregory V Carr; Lee E Schechter; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

10.  Impulsivity as long-term sequelae after chlorpyrifos intoxication: time course and individual differences.

Authors:  D Cardona; G López-Crespo; M C Sánchez-Amate; P Flores; F Sánchez-Santed
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.